Akero Therapeutics, Inc.

US BANCORP \DE\ AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/12/2025

Shares

3,664

Value ($000)

174

Weight

0.0%

2020 Q1 - 2025 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/12/2025	174	0.0%	3,664	9/30/2025
2025 Q2	7/24/2025	164	0.0%	3,065	6/30/2025
2025 Q1	5/8/2025	71	0.0%	1,765	3/31/2025
2024 Q4	2/5/2025	48	0.0%	1,719	12/31/2024
2024 Q3	10/28/2024	49	0.0%	1,711	9/30/2024
2024 Q2	8/7/2024	41	0.0%	1,761	6/30/2024
2024 Q1	5/8/2024	43	0.0%	1,713	3/31/2024
2023 Q4	2/9/2024	74	0.0%	3,177	12/31/2023
2023 Q3	11/3/2023	115	0.0%	2,270	9/30/2023
2023 Q2	8/10/2023	171	0.0%	3,661	6/30/2023
2023 Q1	5/9/2023	123	0.0%	3,225	3/31/2023
2022 Q4	2/13/2023	407	0.0%	7,433	12/31/2022
2022 Q3	10/27/2022	189	0.0%	5,541	9/30/2022
2022 Q2	8/1/2022	21	0.0%	2,255	6/30/2022
2022 Q1	5/11/2022	20	0.0%	1,376	3/31/2022
2021 Q4	2/11/2022	23	0.0%	1,100	12/31/2021
2021 Q3	11/10/2021	25	0.0%	1,100	9/30/2021
2021 Q2	8/5/2021	75	0.0%	3,031	6/30/2021
2021 Q1	4/28/2021	116	0.0%	4,000	3/31/2021
2020 Q2	8/7/2020	19	0.0%	750	6/30/2020
2020 Q1	5/13/2020	16	0.0%	750	3/31/2020